|
|Section2= |Section3= }} CP-154,526 is a potent and selective antagonist of the corticotropin releasing hormone receptor 1 developed by Pfizer. CP-154,526 is under investigation for the potential treatment of alcoholism. == See also == * Antalarmin * Pexacerfont * Corticotropin releasing hormone antagonist 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「CP-154,526」の詳細全文を読む スポンサード リンク
|